Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
03/2003
03/12/2003EP1135121B1 Combination of duloxetine with non-steroidal antiinflammatory drug for treating pain
03/12/2003EP1097127B1 Diacylhydrazine derivatives as integrin inhibitors
03/12/2003EP1091954B1 Process for producing (8-chloro-3,10-dibromo-6,11-dihydro-5h-benzo 5,6]cyclohepta[1,2-b]pyridin-11-yl)-1-piperidine
03/12/2003EP1083891B1 Compounds which interact with the thyroid hormone receptor for the treatment of fibrotic disease
03/12/2003EP1044203B1 3'-epimeric k-252a derivatives
03/12/2003EP0994702B1 Medicament comprising adenosine
03/12/2003EP0979098B1 Method of treating hyperprolactinemia and prolactinomas
03/12/2003EP0964852B1 Indolecarboxylic compounds and their use as pharmaceutical compounds
03/12/2003EP0923548B1 4-aminoethoxy indoles as dopamin d2 agonists and as 5ht 1a ligands
03/12/2003EP0895478B1 Component b as cicatrizant
03/12/2003EP0874830B1 A metalloproteinase inhibitor, a pharmaceutical composition containing it and the pharmaceutical use and method useful for the preparation thereof
03/12/2003EP0858335B1 2-alkylpyrrolidines
03/12/2003EP0787016B1 Secretory leukocyte protease inhibitor (slpi) as an inhibitor of tryptase
03/12/2003EP0729459B1 Phenyl-alkyl imidazoles as h3-receptor antagonists
03/12/2003EP0705339B1 Human cell adhesion protein aamp-1 and uses thereof
03/12/2003EP0672031B1 Catechol diethers as selective pde iv inhibitors
03/12/2003CN1402736A 胶原 Collagen
03/12/2003CN1402733A Angiogenic proteins and uses thereof
03/12/2003CN1402732A Nb heterocyclic 8-modified adenosine derivs.
03/12/2003CN1402728A Method for producing epinastine hydrochloride in high-melting crystal modification
03/12/2003CN1402727A Bicyclic imidazo-3-yl-amine derivs. which are substd. on sixth ring
03/12/2003CN1402722A Arylamine derivs. and their use an anti-telomerase
03/12/2003CN1402721A Benzoimidazole derivs. useful as antiproliferative agents
03/12/2003CN1402720A 2,4-diaminopyrimidine compounds useful as immunosuppressants
03/12/2003CN1402717A Benzothiadiazine derivs., preparation method and pharmaceutical compositions contg. same
03/12/2003CN1402716A Substd. oxazoles and thiazoles derivs. as HPPAR alpha activators
03/12/2003CN1402711A 4-carboxyamino-2-ethyl-1,2,3,4-tetrahydroquinoline crystal as CETP inhibitor
03/12/2003CN1402710A Antipicornaviral compound and compositions, their pharmaceutical uses, and material for their synthesis
03/12/2003CN1402709A 4-pyridinyl-N-acyl-L-phenylalanines
03/12/2003CN1402706A Antidiabetic agents
03/12/2003CN1402702A Beta 2-adrenergic receptor agonists
03/12/2003CN1402642A Solutions and methods for inhibition of pain, inflammation and cartilage degradation
03/12/2003CN1402640A Stabilized liquid polypeptide-confg. pharmaceutical compositions
03/12/2003CN1402639A Pharmaceutical combinations
03/12/2003CN1402635A Agents for relieving carbonyl stress
03/12/2003CN1401657A Gene sequence and use of fish testicle development factor
03/12/2003CN1401656A Gene sequence and use of fish testicle development factor
03/12/2003CN1401385A Summer heat relieving and lithagogue beverage and producing process thereof
03/12/2003CN1401364A Use of compound prescription of pollen and Chinese medicine in preparing medicine for enhancing motor ability
03/12/2003CN1401327A Medicine for treating by-effect caused by chemotherapy and radiotherapy, and producing method thereof
03/12/2003CN1401322A Concentrated clear solution contg. biocefalin as brain metabolism improving medicine for intravenous injection after diluting it
03/12/2003CN1102927C Prepn. of 1-butyl-4-piperidinylmethylamine
03/11/2003WO2002022578A1 (2-azabicyclo[2.2.1]hept-7-yl)methanol derivatives as nicotinic acetylcholine receptor agonists
03/11/2003US6531610 Intermediate acylating carbonate
03/11/2003US6531598 Naphthostyrils
03/11/2003US6531580 Anti-αvβ3 recombinant human antibodies and nucleic acids encoding same
03/11/2003US6531511 2-adamantanemethanamine compounds for treating abnormalities in glutamatergic transmission
03/11/2003US6531510 N,N′-bis(2-hydroxybenzyl)ethylenediamine-N,N′-diacetic acid in iron chelating therapy
03/11/2003US6531507 Stabilized pharmaceutically effective composition and pharmaceutical formulation comprising the same
03/11/2003US6531498 Antiallergens, etc
03/11/2003US6531497 Epothilone derivatives and their synthesis and use
03/11/2003US6531492 Heterocyclo-alkylsulfonyl pyrazole derivatives as anti-inflammatory/analgesic agents
03/11/2003US6531486 Reacting quinapril or acid addition salt thereof with alkaline magnesium compound in presence of solvent to form quinapril magnesium
03/11/2003US6531479 Anti-cancer compounds
03/11/2003US6531477 Treating cancer or other proliferative diseases
03/11/2003US6531474 Inhibitors of caspases
03/11/2003US6531473 Method of treatment using arylalkylpyridazinones
03/11/2003US6531472 Tetralone derivatives
03/11/2003US6531471 Morpholinone and morpholine derivatives and uses thereof
03/11/2003US6531468 Inhibiting serotonin reuptake in the central nervous system of a mammal
03/11/2003US6531459 Vitamin D derivatives with phosphorus atoms in the side chains
03/11/2003US6531449 Hexahydropyrazolo[4,3,-c]pyridine metabolites
03/11/2003US6531297 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof
03/11/2003US6531140 Anti-irritant compositions containing a cyclic nucleotide
03/11/2003CA2421936A1 (2-azabicyclo[2.2.1]hept-7-yl)methanol derivatives as nicotinic acetylcholine receptor agonists
03/11/2003CA2264254C Phosphinic acid amides as matrix metalloprotease inhibitors
03/11/2003CA2242351C Novel tricyclic compounds and drug compositions containing the same
03/11/2003CA2102187C Use of atipamezole for the treatment of male sexual impotence
03/11/2003CA2041620C An ortho-lithiation process for the synthesis of 2-substituted-1-(tetrazol-5-yl) benzenes
03/10/2003CA2401358A1 Diacid-substituted heteroaryl derivatives as matrix metalloproteinase inhibitors
03/10/2003CA2401319A1 Use of statins to inhibit formation of osteoclasts
03/07/2003WO2002020472A1 Substituted phenylcyclohexane carboxylic acid amides and the use thereof
03/07/2003CA2421781A1 Substituted phenylcyclohexane carboxylic acid amides and the use thereof
03/06/2003WO2003019457A2 Method of optimizing growth hormone replacement
03/06/2003WO2003019198A2 Methods relating to treatment of atherosclerosis
03/06/2003WO2003019196A2 Diagnosis and treatment of atherosclerosis
03/06/2003WO2003019146A2 High throughput screening assays using fatty acid synthetic enzymes
03/06/2003WO2003018823A1 Obesity related genes expressed at least in the hypotalamus, liver or pancreas
03/06/2003WO2003018817A1 Yeast membrane protein expression system and its application in drug screening
03/06/2003WO2003018806A1 Novel human bmcc1 gene
03/06/2003WO2003018803A1 Established fat cell precursors, method of preparing the same and method of using the same
03/06/2003WO2003018799A2 Modulators of bone homeostasis identified in a high-throughput screen
03/06/2003WO2003018793A1 Novel gene having guanine nucleotide exchange factor-like sequence
03/06/2003WO2003018788A2 Improved nitroreductase enzymes
03/06/2003WO2003018756A2 Methods for preparing purified prostaglandin e synthase
03/06/2003WO2003018743A2 Emu-based formulations for wound treatment
03/06/2003WO2003018690A1 Composition containing fine particles for supporting biologically active substance thereon or having the same supported thereon and method for preparing these
03/06/2003WO2003018640A2 Use of heparinoid derivatives for treating and diagnosing diseases that can be treated by heparinoids
03/06/2003WO2003018632A2 Epitope regions of a thyrotrophin (tsh) receptor, uses thereof and antibodies thereto
03/06/2003WO2003018626A2 Novel genetic products from ashbya gossypii, associated with the structure of the cell wall or the cytoskeleton
03/06/2003WO2003018615A1 Novel crystal of cyclic lipopeptide compound
03/06/2003WO2003018606A2 Casein derived peptides and uses thereof in therapy
03/06/2003WO2003018589A1 Novel 4-aminofuropyrimidines and the use thereof
03/06/2003WO2003018586A1 Substituted-aryl 7-aza[2.2.1]bicycloheptanes for the treatment of disease
03/06/2003WO2003018585A1 Substituted-heteroaryl-7-aza[2.2.1]bicycloheptanes for the treatment of disease
03/06/2003WO2003018582A1 Novel imidazopyridine compounds with therapeutic effect
03/06/2003WO2003018581A1 1,2-dihydro-2-oxo-1,8-naphthyridine derivative
03/06/2003WO2003018580A1 Naphthyridine derivative
03/06/2003WO2003018579A1 Alkyne-aryl phosphodiesterase-4 inhibitors
03/06/2003WO2003018574A1 Rapamycin dialdehydes
1 ... 812 813 814 815 816 817 818 819 820 821 822 823 824 825 826 827 828 829 830 831 832 ... 1564